Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 563 entries
View as:

Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations

Phase: N/A Priority: Normal
NCT ID: NCT03786796 Org: User:
Start: 06/03/19 End: 03/31/28 Due: 03/31/29

Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03307564 Org: User:
Start: 06/06/18 End: 12/31/22 Due: 12/31/23

TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05132803 Org: User:
Start: 08/31/21 End: 01/18/22 Due: 01/18/23

Transitoriness in Cancer Patients, Psychosocial Issues in Cancer Care

Phase: N/A Priority: Normal
NCT ID: NCT00364078 Org: User:
Start: 06/30/06 End: 08/31/07 Due: 08/31/08

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03471650 Org: User:
Start: 03/29/18 End: 03/07/27 Due: 03/07/28

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06796543 Org: User:
Start: 03/25/25 End: 03/31/30 Due: 03/31/31

Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02080416 Org: User:
Start: 07/31/14 End: 02/29/16 Due: 02/28/17

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03521830 Org: User:
Start: 11/27/18 End: 03/31/27 Due: 03/31/28

Assessing the Acceptability of the Use of a Mobile Health App Among Young Adult Female Survivors of Childhood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03242200 Org: User:
Start: 09/26/17 End: 03/11/21 Due: 03/11/22

Transcranial Direct Current Stimulation (tDCS) to Improve Fatigue and Cognitive Function

Phase: N/A Priority: Normal
NCT ID: NCT03487601 Org: User:
Start: 12/12/17 End: 02/16/19 Due: 02/16/20

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Phase: N/A Priority: Normal
NCT ID: NCT06027086 Org: User:
Start: 02/12/24 End: 09/01/33 Due: 09/01/34

Concentration and Activity of Lapatinib in Vestibular Schwannomas

Phase: N/A Priority: Normal
NCT ID: NCT00863122 Org: User:
Start: 06/30/09 End: 08/31/14 Due: 08/31/15

Post-Operative Outcomes of Low Thermal Dissection vs. Traditional Electrosurgery

Phase: N/A Priority: Normal
NCT ID: NCT03711916 Org: User:
Start: 03/17/17 End: 12/03/18 Due: 12/03/19

Patient and Provider Initiated Survivorship Care Planning

Phase: N/A Priority: Normal
NCT ID: NCT02405819 Org: User:
Start: 02/28/15 End: 02/29/16 Due: 02/28/17

GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03161379 Org: User:
Start: 02/02/18 End: 02/28/24 Due: 02/28/25

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Phase: N/A Priority: Normal
NCT ID: NCT02096588 Org: User:
Start: 05/20/14 End: 07/26/23 Due: 07/26/24

ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00770471 Org: User:
Start: 07/13/09 End: 03/01/12 Due: 03/01/13

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02644291 Org: User:
Start: 05/31/16 End: 06/09/22 Due: 06/09/23

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00024466 Org: User:
Start: 04/30/01 End: 04/30/09 Due: 04/30/10

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

Phase: N/A Priority: Normal
NCT ID: NCT03767582 Org: User:
Start: 12/12/19 End: 09/30/24 Due: 09/30/25

Renal Retention in High Grade Upper Tract Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05656235 Org: User:
Start: 11/25/24 End: 06/30/29 Due: 06/30/30

Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

Phase: N/A Priority: Normal
NCT ID: NCT01342289 Org: User:
Start: 08/31/11 End: 03/31/18 Due: 03/31/19

Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01886105 Org: User:
Start: 08/19/13 End: 06/11/17 Due: 06/11/18

A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT03593993 Org: User:
Start: 05/19/18 End: 07/07/23 Due: 07/07/24

Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00006355 Org: User:
Start: 05/31/00 End: 10/31/06 Due: 10/31/07